AlphaYouFA
Insider selling
Fred Aslan sold $256K of Artiva Biotherapeutics, Inc. (ARTV) stock
Fred Aslan, Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV), sold 23,429 shares of ARTV stock worth $256K, per an SEC Form 4 filed Sep 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 8, 2026, 1 day before it was made public.
ARTV has moved -28.0% since the trade date, from $10.88 to $7.83 (Sep 21, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 1 day
- Price since
- -28.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More ARTV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.